Mode
Text Size
Log in / Sign up

NSP antibody detection aids DIVA interpretation in foot-and-mouth disease but has key limitsNew ways to tell if livestock are vaccinated against disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret NSP serology for DIVA only with vaccine purity, history, kinetics, species, and cut-offs; not standalone for shedding or carrier status.

This systematic mini review evaluates the utility of non-structural protein (NSP) antibody detection for differentiating infected from vaccinated animals (DIVA) in foot-and-mouth disease. The authors synthesize evidence from vaccinated populations, focusing on the accuracy of DIVA interpretation.

Key findings indicate that NSP antibody detection supports DIVA interpretation only when multiple factors are taken into account: vaccine purity, vaccination history, antibody kinetics, host species, and assay cut-offs. The review emphasizes that NSP serology is not a standalone test for current shedding, persistent infection, or carrier status.

The authors note limitations, including that NSP serology alone cannot confirm current shedding or carrier status. The review does not report sample sizes, effect sizes, or confidence intervals, reflecting the qualitative nature of the evidence.

For practice, NSP serology is most useful when combined with vaccination records, structural protein serology, RT-qPCR, and epidemiological investigation. Clinicians should interpret NSP results cautiously and not rely on them in isolation.

How this fits prior evidence

This mini review extends prior coverage on foot-and-mouth disease diagnostics by focusing on DIVA serology using NSP antibodies. While a previous review considered in vitro assays for vaccine immunogenicity assessment as a complementary tool with validation gaps, the current review addresses the specific utility of NSP serology for distinguishing infected from vaccinated animals. It confirms that NSP detection is not a standalone test and must be integrated with other methods, aligning with the earlier emphasis on complementary approaches.

When a contagious disease like foot-and-mouth disease hits a farm, it is vital to know which animals were actually exposed to the virus and which ones were simply protected by a vaccine. This distinction helps officials manage outbreaks more effectively. Scientists are looking at non-structural protein (NSP) antibodies as a way to tell these two scenarios apart.

Research shows that testing for these specific proteins can help identify vaccination history, but it is not a perfect tool on its own. To be accurate, the test must take into account several factors like the purity of the vaccine used, the timing of the shots, and the specific species of the animal. It works best when combined with other methods like genetic testing and detailed farm records.

It is important to note that these tests cannot tell you if an animal is currently spreading the virus or carrying it in its system right now. Because the results depend on so many variables, experts recommend using this method as part of a larger investigation rather than a single standalone test.

What this means for you:
NSP antibody tests can help identify vaccination history but cannot confirm if an animal is currently shedding virus.

Common questions

Can this test tell if an animal is currently spreading the virus?

No, this specific type of testing cannot be used as a standalone way to see if an animal is currently shedding the virus, has a persistent infection, or is acting as a carrier. It is mainly useful for looking at the history of exposure and vaccination.

How accurate are these antibody tests?

The accuracy of these tests depends on several factors. To be reliable, experts must consider vaccine purity, the animal's vaccination history, how antibodies develop over time, the specific species of the host, and the specific limits set for the test results.

Is this test better than current methods?

This method is most useful when it is combined with other tools. To get a clear picture, it should be used alongside vaccination records, structural protein testing, and molecular tests like RT-qPCR during an investigation.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Surveillance for foot-and-mouth disease (FMD) in vaccinated populations requires tests that distinguish vaccine-induced immunity from infection-associated exposure. Structural protein antibodies help assess vaccine response and serotype-specific protection, whereas antibodies to foot-and-mouth disease virus (FMDV) non-structural proteins (NSPs) support DIVA (differentiating infected from vaccinated animals) interpretation only when vaccine purity and vaccination history are considered. Residual NSPs in incompletely purified vaccines, repeated vaccination, antibody kinetics, host species and assay cut-offs all influence interpretation. This Mini Review examines NSP antibody detection based on 3ABC, 3B/VPg repeated-epitope design, complementary NSP targets, competitive or blocking ELISA, multi-species-compatible assays and emerging field-deployable formats. It does not rank platforms as universally superior; instead, it considers reported performance, validation context and field setting. NSP serology is most useful when combined with vaccination records, structural protein serology, RT-qPCR and epidemiological investigation. It can flag possible subclinical exposure or post-outbreak risk, but it is not a standalone test for current shedding, persistent infection or carrier status.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.